Neuropsychiatric manifestations of alkali metal deficiency and excess.
The alkali metals from the Group IA of the periodic table (lithium, sodium, potassium, rubidium, cesium and francium) are reviewed. The neuropsychiatric aspects of alkali metal deficiencies and excesses (intoxications) are described. Emphasis was placed on lithium due to its clinical uses. The signs and symptoms of these conditions are characterized by features of an organic brain syndrome with delirium and encephalopathy prevailing. There are no clinically distinctive features that could be reliably used for diagnoses. Sodium and potassium are two essential alkali metals in man. Lithium is used as therapeutic agent in bipolar affective disorders. Rubidium has been investigated for its antidepressant effect in a group of psychiatric disorders. Cesium is under laboratory investigation for its role in carcinogenesis and in depressive illness. Very little is known of francium due to its great instability for experimental study.
D002586:Cesium / Q000009:adverse effects / Q000172:deficiency; D005605:Francium / Q000009:adverse effects / Q000172:deficiency; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced*; D008672:Metals, Alkali / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D011191:Potassium Deficiency / Q000523:psychology; D012413:Rubidium / Q000009:adverse effects / Q000172:deficiency; D012964:Sodium / Q000009:adverse effects / Q000172:deficiency
D008672:Metals, Alkali; D005605:Francium; D002586:Cesium; D012964:Sodium; D012413:Rubidium